4th Quarter - Report

KING & SPALDING LLP for KANEKA PHARMA AMERICA, LLC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment

Foreign entity interest: Kaneka Corporation, as identified on the LD-1, has an interest in the issues listed above as the owner of Kaneka Pharma America, LLC.

LobbyistCovered position, as disclosed
MICHAEL A ANDREWS —
JEANNINE M BENDER Staff, Rep. Barton
WILLIAM CLARKSON Leg. Asst. Sen. Collins; Staff Asst. Sen. Coverdell
ALEXANDER ("ANDER") M. CRENSHAW U.S. Representative (FL-04), 2001-2017
DAVID JOSEPH FARBER —
ALLISON F KASSIR —
PREEYA NORONHA PINTO Deputy GC, Principal Deputy GC, Acting GC, HHS

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.